跳到正文
Molecular Therapy· Oliver Gough, Christos Georgiadis, Roland Preece, Renuka Kadirkamanathan, Waseem Qasim·· 13 天前AI 评分38

完全无病毒的CAR T细胞能否媲美慢病毒转导的通用细胞?

Are entirely virus-free CAR T cells as good as lentiviral transduced universal cells?

AI 导读

Qasim等人在TRAC或CD3ζ位点通过靶向CRISPR插入构建抗CD20 41BB-CD3ζ-CAR T细胞,并与现有慢病毒基准比较,非病毒生产的产品体外功能相当,但体内清除白血病的效果总体较弱。结果提示非病毒方法有前景,但用于人体比较前仍需进一步优化并以慢病毒方法为基准仔细评估。

原文摘要

出版方登记 · Crossref

Chimeric Antigen Receptor (CAR) T cells are now established as therapies for some haematological malignancies. While lentiviral or γ-retroviral vectors are commonly used for CAR delivery due to their efficiency and stable integration, supply constraints have created bottlenecks to wider applications and access. Alternatively, genome editing tools such as CRISPR-Cas9 can insert CAR genes by homology-directed repair (HDR) into specific genomic loci. ‘Universal’ donor CAR-T cells devoid of endogenous TCRαβ after CRISPR-Cas9-mediated editing of the T cell receptor alpha ( TRAC ) locus are being investigated for more cost-effective, ‘off-the-shelf’ therapies. Targeting insertion of CARs into the TRAC locus places transcription under the control of native regulatory machinery while simultaneously disrupting endogenous TCRαβ, and this has been reported to reduce exhaustion and extend persistence in modelling studies using humanised mice. We compared anti-CD20 CAR-T cells, generated with CAR inserts at either TRAC or CD3ζ loci using entirely virus-free manufacture, and universal CAR20-T cells generated using existing lentiviral procedures and CRISPR/Cas9 knockout. While non-viral cell yields were lower than lentiviral products cytotoxic function in vitro was comparable between groups. Studies in humanised murine models of leukaemia inhibition found non-viral CAR20-T cells were generally less efficacious than LV-CAR20 and exhibited more exhausted phenotypes. Non-viral approaches offer the prospect of sophisticated editing and precise CAR insertion but careful preclinical evaluation and well-designed clinical trials benchmarked against lentiviral approaches are recommended.

页面未能读取全文,以上为出版方登记的摘要;方法与图表见原文

来源:Molecular Therapy · cell.com